The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Belov Yu.V.

RNTsKh im. akad. B.V. Petrovskogo RAMN

Charchian É.R.

RNTsKh im. akad. B.V. Petrovskogo RAMN

Salagaev G.I.

Chair of Cardiovascular Surgery and Interventional Cardiology, I.M. Sechenov First Moscow State Medical University (head — MD R.N. Komarov), acad. B.V. Petrovsky Russian Research Center for Surgery (director — acad. of RAS Yu.V. Belov), Moscow, Russia

Functional mitral regurgitation in aortic valve disease patients: state of the art

Authors:

Belov Yu.V., Charchian É.R., Salagaev G.I.

More about the authors

Read: 2121 times


To cite this article:

Belov YuV, Charchian ÉR, Salagaev GI. Functional mitral regurgitation in aortic valve disease patients: state of the art. Russian Journal of Cardiology and Cardiovascular Surgery. 2016;9(1):69‑75. (In Russ.)
https://doi.org/10.17116/kardio20169169-75

Recommended articles:
Sele­ction of opti­mal aortotomy in various cardiac surgeries. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(3):306-309
Surgical treatment of patients with functional mitral regu­rgitation and aortic valve disease. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(3):310-325
Septal myectomy in aortic valve replacement for severe aortic stenosis. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(3):326-334
Meta-analysis on the rele­vance of septal myectomy in aortic valve replacement. Piro­gov Russian Journal of Surgery. 2025;(10-2):94-99

References:

  1. Absil B, Dagenais F, Mathieu P, et al. Does moderate mitral regurgitation impact early or mid-term clinical outcome in patients undergoing isolated aortic valve replacement for aortic stenosis? Eur J Cardiothorac Surg. 2003;24:217-222.
  2. Agricola E, Oppizzi M, Galderisi M, et al. Role of regional mechanical dyssynchrony as a determinant of functional mitral regurgitation in patients with left ventricular systolic dysfunction. Heart. 2006;92:1390-1395.
  3. Barreiro CJ, Patel ND, Fitton TP, et al. Aortic valve replacement and concomitant mitral valve regurgitation in the elderly: impact on survival and functional outcome. Circulation. 2005;112:1443- 1447.
  4. Bax JJ, Braun J, Somer ST, et al. Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation. 2004 Sep 14;110(1):II103-II108.
  5. Bonow RO, Carabello BA, Chatterjee K, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 Focused update incorporated into the ACC/ AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52:e1-e142.
  6. Bonow RO, Lakatos E, Maron BJ, Epstein SE. Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation. 1991;84:1625-1635.
  7. Bonow RO, Rosing DR, McIntosh CL, et al. The natural history of asymptomatic patients with aortic regurgitation and normal left ventricular function. Circulation. 1983;68:509-517.
  8. Brasch AV, Khan SS, DeRobertis MA, et al. Change in mitral regurgitation severity after aortic valve replacement for aortic stenosis. Am J Cardiol. 2000;85:1271-1274.
  9. Breithardt OA, Sinha AM, Schwammenthal E, et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol. 2003;41:765-770.
  10. Brener SJ, Duffy CI, Thomas JD, Stewart WJ. Progression of aortic stenosis in 394 patients: relation to changes in myocardial and mitral valve dysfunction. J Am Coll Cardiol. 1995;25:305-310.
  11. Briand M, Dumesnil JG, Kadem L, et al. Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: implications for diagnosis and treatment. J Am Coll Cardiol. 2005;46:291-298.
  12. Bristow MR, Saxon LA, Boehmer J, et al. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators: cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-2150.
  13. Caballero-Borrego J, Gуmez-Doblas JJ, Cabrera-Bueno F, et al. Incidence, associated factors and evolution of non- evere functional mitral regurgitation in patients with severe aortic stenosis undergoing aortic valve replacement. Eur J Cardiothorac Surg. 2008;34:62-66.
  14. Calafiore AM, Di Mauro M, Gallina S, et al. Mitral valve surgery for chronic ischemic mitral regurgitation. Ann Thorac Surg. 2004;77:1989-1997.
  15. Calafiore AM, Mazzei V, Iacт AL, et al. Impact of ischemic mitral regurgitation on long-term outcome of patients with ejection fraction above 0.30 undergoing first isolated myocardial revascularization. Ann Thorac Surg. 2008;86:458-464; discussion 464-465.
  16. Carabello B, Green L, Grossman W, et al. Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure. Circulation. 1980;62:42-52.
  17. Carabello B, Williams H, Gash A, et al. Hemodynamic predictors of outcome in patients undergoing valve replacement. Circulation. 1986;74:1309-1316.
  18. Chaput M, Handschumacher MD, Guerrero JL, et al. Mitral Leaflet Adaptation to Ventricular Remodeling: Prospective Changes in a Model of Ischemic Mitral Regurgitation. Circulation. 2009;120:S99-S103.
  19. Chaput M, Handschumacher MD, Tournoux F, et al. Mitral Leaflet Adaptation to Ventricular Remodeling: Occurrence and Adequacy in Patients With Functional Mitral Regurgitation. Circulation. 2008;118:845-852.
  20. Chenoweth DE, Cooper SW, Hugli TE, et al. Complement activation during cardiopulmonary bypass: evidence for generation of- C3a and C5a anaphylatoxins. N Engl J Med. 1981;304:497-503.
  21. Barreiro CJ, Patel ND, Fitton TP. Aortic Valve Replacement and Concomitant Mitral Valve Regurgitation in the Elderly: Impact on Survival and Functional Outcome. Circulation. 2005;112:I- 443-I-447.
  22. Come PC, Riley MF, Ferguson JF, et al. Prediction of severity of aortic stenosis: accuracy of multiple non-invasive parameters. Am J Med. 1988;85:29-37.
  23. Donal E, De Place C, Kervio G, et al. Mitral regurgitation in dilated cardiomyopathy: value of both regional left ventricular contractility and dyssynchrony. Eur J Echocardiogr. 2009;10:133-138.
  24. D’Onofrio A, Gasparetto V, Napodano M, et al. Impact of preoperative mitral valve regurgitation on outcomes after transcatheter aortic valve implantation. Eur J Cardiothorac Surg. 2012;41:1271- 1276.
  25. Dal-Bianco JP, Aikawa E, Bischoff J, et al. Active Adaptation of the Tethered Mitral Valve: Insights Into a Compensatory Mechanism for Functional Mitral Regurgitation. Circulation. 2009;120:334-342.
  26. Angeloni E, Melina G, Pibarot P, et al. Impact of Prosthesis-Patient Mismatch on the Regression of Secondary Mitral Regurgitation After Isolated Aortic Valve Replacement With a Bioprosthetic Valve in Patients With Severe Aortic Stenosis. Circ Cardiovasc Imaging. 2012;5:36-42.
  27. Erlebacher JA, Barbarash S. Intraventricular conduction delay and functional mitral regurgitation. Am J Cardiol. 2001;88:83-86.
  28. Feroze Mahmood, Warraich HJ, Gorman JHIII, et al. Changes in Mitral Annular Geometry after Aortic Valve Replacement: A Three-Dimensional Transesophageal Echocardiographic Study. J Heart Valve Dis. 2012 November;21(6):696-701.
  29. Gaasch WH, Meyer TE. Left ventricular response to mitral regurgitation: implications for management. Circulation. 2008;118(22):2298-2303.
  30. Giannini C, Petronio AS, De Carlo M, et al. The incremental value of valvuloarterial impedance in evaluating the results of transcatheter aortic valve implantation in symptomatic aortic stenosis. J Am Soc Echocardiogr. 2012;25:444- 453.
  31. Grossi EA, Bizekis CS, LaPietra A, et al. Late results of isolated mitral annuloplasty for "functional" ischemic mitral insufficiency. J Card Surg. 2001;16(4):328-332.
  32. Grossman W, Jones D, McLaurin L. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest. 1975;56:56- 64.
  33. Guler Ahmet, Dundar Cihan, Tigen Kurşat. Functional mitral regurgitation and papillary muscle dyssynchrony in patients with left ventricular systolic dysfunction. Anadolu Kardiyol Derg. 2011;11:450-455.
  34. Gunther S, Grossman W. Determinants of ventricular function in pressure-overload hypertrophy in man. Circulation. 1979;59:679- 688.
  35. Hachicha Z, Dumesnil JG, Pibarot P. Usefulness of the valvuloarterial impedance to predict adverse outcome in asymptomatic aortic stenosis. J Am Coll Cardiol. 2009;54:1003- 1011.
  36. Harling L, Saso S, Jarral O, et al. Aortic valve replacement for aortic stenosis in patients with concomitant mitral regurgitation: should the mitral valve be dealt with? Eur J Cardiothorac Surg. 2011;40:1087-1096.
  37. Harris KM, Malenka DJ, Haney MF, et al. Improvement in mitral regurgitation after aortic valve replacement. Am J Cardiol. 1997;80:741-745.
  38. He S, Fontaine AA, Schwammenthal E, Yoganathan AP, Levine RA. Integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies. Circulation. 1997;96:1826-1834.
  39. Huber D, Grim J, Koch R, Krayenbuehl H. Determinants of ejection performance in aortic stenosis. Circulation. 1981;641:26- 34.
  40. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro heart survey on valvular heart disease. Eur Heart J. 2003;24:1231-1243.
  41. Christenson JT, Jordan B, Bloch A, Schmuziger M. Should a Regurgitant Mitral Valve Be Replaced Simultaneously with a Stenotic Aortic Valve? Texas Heart Institute Journal. 2000;27(4):350-355.
  42. Judge DP, Markwald RR, Hagege AA, Levine RA. Translational research on the mitral valve: from developmental mechanisms to new therapies. J Cardiovasc Transl Res. 2011;4:699-701.
  43. Karvounis HI, Dalamaga EG, Papadopoulos CE, et al. Improved papillary muscle function attenuates functional mitral regurgitation in patients with dilated cardiomyopathy after cardiac resynchronization therapy. J Am Soc Echocardiogr. 2006;19:1150- 1157.
  44. Kazaki H, Bazaz R, Scwartzman D, Dohbi K, Lif Sade L, Gorcsan J III. A mechanism for the immediate reduction in mitral regurgitation after cardiac resynchronisation therapy. J Am Coll Cardiol. 2004;44:1619-1625.
  45. Kentaro Shibayama, Kenji Harada, Javier Berdejo et.al. Effect of Transcatheter Aortic Valve Replacement on the Mitral Valve Apparatus and Mitral Regurgitation Real-Time Three- Dimensional Transesophageal Echocardiography Study. Circ Cardiovasc Imaging. 2014;7:344-351.
  46. Kim YH, Czer LS, Soukiasian HJ, et al. Ischemic mitral regurgitation: revascularization alone versus revascularization and mitral valve repair. Ann Thorac Surg. 2005 Jun;79(6):1895-1901.
  47. Kirklin JK, Westaby S, Blackstone EH, et al. Complement and the damaging effects ofcardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983;86:845-857.
  48. Kono T, Sabbah HN, et al. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol. 1992;20(7):1594-1598.
  49. Kunzelman KS, Quick DW, Cochran RP. Altered collagen concentration in mitral valve leaflets: biochemical and finite element analysis. The Annals of Thoracic Surgery. 1998;66:S198-S205.
  50. Lancellotti P, Moura L, Pierard LA, et al: European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2. Mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr. 2010;11:307-332.
  51. Lansac E, Lim KH, Shomura Y, et al. Dynamic balance of the aortomitral junction. J Thorac Cardiovasc Surg. 2002;123:911-918.
  52. Leavitt BJ, Baribeau YR, DiScipio AW, et al. Northern New England Cardiovascular Disease Study Group. Outcomes of patients undergoing concomitant aortic and mitral valve surgery in northern New England. Circulation. 2009;120:S155-S162.
  53. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-1607.
  54. Levine RA, Schwammenthal E. Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. Circulation. 2005;112:745-758.
  55. Lindeboom JE, Jaarsma W, Kelder JC, Morshuis WJ, Visser CA. Mitral valve repair is not always needed in patients with functional mitral regurgitation undergoing coronary artery bypass grafting and/or aortic valve replacement. Netherlands Heart Journal. 2005;13(5):175-180.
  56. Llaneras MR, Nance ML, Streicher JT, et al. Large animal model of ischemic mitral regurgitation. Ann Thorac Surg. 1994;57:432-439.
  57. Magne J, Senechal M, Dumesnil JG, et al: Ischemic mitral regurgitation: a complex multifaceted disease. Cardiology. 2009;112:244-259.
  58. Mann DL. Mechanisms and models in heart failure. A combinatorial approach. Circulation. 1999;100:999-1008.
  59. Marichaux S, Pinzon C, Poueymidanette M, et al: Elevated left atrial pressure estimated by Doppler echocardiography is a key determinant of mitral valve tenting in functional mitral regurgitation. Heart. 2010;96:289- 297.
  60. Matsumura Y, Gillinov AM, Toyono M, et al. Echocardiographic predictors for persistent functional mitral regurgitation after aortic valve replacement in patients with aortic valve stenosis. Am J Cardiol. 2010;106:701-706.
  61. Moazami N, Diodato MD, Moon MR, et al. Does functional mitral regurgitation improve with isolated aortic valve replacement? J Card Surg. 2004;19:444-448.
  62. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005- 1011.
  63. Ogawa S, Hubbard FE, Mardelli TJ, Dreifus LS. Cross-sectional echocardiographic spectrum of papillary muscle dysfunction. Am Heart J. 1979;97:312-321.
  64. Otsuji Y, Handschumacher MD, et al. Insights from threedimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry. Circulation. 1997;96(6):1999-2008.
  65. Park S-M, Park SW, Casaclang-Verzosa G, et al: Diastolic dysfunction and left atrial enlargement as contributing factors to functional mitral regurgitation in dilated cardiomyopathy: data from the Acorn trial. Am Heart J. 2009;157:762:e3-e10.
  66. Perloff JK, Roberts WC. The mitral apparatus. Functional anatomy of mitral regurgitation. Circulation. 1972;46(2):227-239.
  67. Pibarot P, Dumesnil JG. Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation. 2009;119:1034-1048.
  68. Pibarot P, Dumesnil JG. The relevance of prosthesis-patient mismatch after aortic valve replacement. Nat Clin Pract Cardiovasc Med. 2008;5:764-765.
  69. Porciani MC, Macioce R, Demarchi G, et al. Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure. Eur J Echocardiogr. 2006;7:31-39.
  70. Rahimtoola SH. The problem of valve prosthesis-patient mismatch. Circulation. 1978;58:20-24.
  71. Rankin JS, Hammill BG, Ferguson TBJr, et al. Determinants of operative mortality in valvular heart surgery. J Thorac Cardiovasc Surg. 2006 Mar;131(3):547-557.
  72. Ross JJr. Afterload mismatch in aortic and mitral valve disease: implications for surgical therapy. J Am Coil Cardiol. 1985;5:811- 826.
  73. Ruel M, Kapila V, Price J, et al. Natural history and predictors of outcome in patients with concomitant secondary mitral regurgitation at the time of aortic valve replacement. Circulation. 2006;114(Suppl I):1541-1546.
  74. Sabbah HN, Rosman H, Kono T, et al. On the mechanism of secondary mitral regurgitation. Am J Cardiol. 1993;72:1074-1076.
  75. Sabbah HN, Kono T, et al. Left ventricular shape changes during the course of evolving heart failure. Am J Physiol. 1992;263(1 Pt. 2):H266-H270.
  76. Salgo IS, Gorman JHIII, Gorman RC. Effect of annular shape and leaflet curvature in reducing mitral leaflet stress. Circulation. 2002;39:2651-2656.
  77. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-2198.
  78. Soyama A, Kono T, Mishima T, et al. Intraventricular dyssynchrony may play a role in the development of mitral regurgitation in dilated cardiomyopathy. J Card Fail. 2005;11:631- 637.
  79. Takeda K, Matsumiya G, Sakaguchi T, et al. Impact of untreated mild-to-moderate mitral regurgitation at the time of isolated aortic valve replacement on late adverse outcomes. Eur J Cardiothorac Surg. 2010 May;37(5):1033-1038.
  80. Tassan-Mangina S, Metz D, Nazeyllas P, et al. Factors determining early improvement in mitral regurgitation after aortic valve replacement for aortic valve stenosis: a transthoracic and transesophageal prospective study. Clin Cardiol. 2003;26:127-131.
  81. Tigen K, Karaahmet T, Dundar C, et al. The importance of papillary muscle dyssynchrony in predicting the severity of functional mitral regurgitation in patients with nonischaemic dilated cardiomiopathy: a two-dimensional speckletracking echocardiography study. Eur J Echocardiogr. 2010;11:671-676.
  82. Tigen K, Karaahmet T, Gurel E, et al. Papillary muscle dyssynchrony as a cause of functional mitral regurgitation in nonischemic dilated cardiomyopathy patients with narrow QRS complexes. Anadolu Kardiyol Derg. 2009;9:196-203.
  83. Toggweiler S, Boone RH, Rodis-Cabau J, et al. Transcatheter aortic valve replacement: outcomes of patients with moderate or severe mitral regurgitation. J Am Coll Cardiol. 2012;59:2068-2074.
  84. Tunick PA, Gindea A, Kronzon I. Effect of aortic valve replacement for aortic stenosis on severity of mitral regurgitation. Am J Cardiol. 1990;65:1219-1221.
  85. Turner JS, Morgan CJ, Thakrar B, et al. Difficulties in predicting outcome in cardiac surgery patients. Crit Care Med. 1995;23:1843- 1850.
  86. Van de Veire NR, De Sutter J. Effect of ischemic mitral regurgitation on the ratio of early transmitral flow velocity to mitral annulus early diastolic velocity in patients with stable coronary artery disease. Am J Cardiol. 2006;97:1449-1451.
  87. Vicchio M, Della Corte A, De Santo LS, et al. Prosthesis-patient mismatch in the elderly: survival, ventricular mass regression and quality of life. Ann Thorac Surg. 2008;86:1791-1797.
  88. Waisbren EC, Stevens LM, Avery EG, et al. Changes in mitral regurgitation after replacement of the stenotic aortic valve. Ann Thorac Surg. 2008;86:56-62.
  89. Wisenbaugh T, Booth D, DeMaria A, et al. Relationship of contractile state to ejection performance in patients with chronic aortic valve disease. Circulation. 1986;73:47-53.
  90. Ypenburg C, Lancellotti P, Tops LF, et al. Acute effects of initiation and withdrawal of cardiac resynchronization therapy on papillary muscle dyssynchrony and mitral regurgitation. J Am Coll Cardiol. 2007;50:2071-2077.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.